|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Net amortization of securities premiums and discounts, net | |||||
| Provision for credit losses | |||||
| (Reversal of) provision for credit losses | |||||
| Depreciation | |||||
| Net accretion of deferred loan fees and costs | |||||
| Deferred income tax expense (benefit) | |||||
| Realized and unrealized loss (gain) on equity securities | |||||
| Unrealized (gain) loss on equity securities | |||||
| Impairment of real estate owned | |||||
| Loss on sale of real estate owned | |||||
| Earnings on bank owned life insurance | |||||
| Loss on disposition of business | |||||
| Loss (gain) on dispositions of premises and equipment | |||||
| ESOP compensation expense | |||||
| Compensation expense related to stock options | |||||
| Compensation expense related to restricted stock | |||||
| Decrease (increase) in accrued interest receivable | |||||
| Increase in other assets | |||||
| Decrease in accounts payable - loan closing | |||||
| Increase in accounts payable and accrued expenses | |||||
| Net Cash Provided by Operating Activities | |||||
| Cash Flows from Investing Activities: | |||||
| Net increase in loans | |||||
| Proceeds from sale of loans | |||||
| Principal repayments on securities available-for-sale | |||||
| Proceeds from sale of real estate owned | |||||
| Principal repayments on securities held-to-maturity | |||||
| Purchase of marketable equity securities | |||||
| Proceeds from bank owned life insurance | |||||
| Purchase of securities held-to-maturity | |||||
| Purchase of FHLB stock | |||||
| Redemption of FHLB stock | |||||
| Purchases of premises and equipment | |||||
| Net Cash Used in Investing Activities | |||||
| Cash Flows from Financing Activities: | |||||
| Net (decrease) increase in deposits | |||||
| Proceeds from FRB borrowing | |||||
| Repayment of FRB borrowing | |||||
| Repayment of FHLB of NY advances | |||||
| Net proceeds (repayments) from borrowings | |||||
| Stock repurchases | |||||
| Stock option exercised | |||||
| Increase (decrease) in advance payments by borrowers for taxes and insurance | |||||
| Cash dividends paid | |||||
| Net Cash Provided by Financing Activities | |||||
| Net Increase in Cash and Cash Equivalents | |||||
| Cash and Cash Equivalents - Beginning | |||||
| Cash and Cash Equivalents - Ending | |||||
| Supplementary Cash Flows Information: | |||||
| Income taxes paid: Federal | |||||
| Income taxes paid: State and local | |||||
| Total income taxes paid | |||||
| Interest paid | |||||
| Supplementary Disclosure of Non-Cash Investing and Financing Activities: | |||||
| Recognition of right of use asset - operating | |||||
| Recognition of lease liability - operating | |||||
| Recognition of real estate owned | |||||
| Sale of real estate owned | |||||
| Dividends declared and not paid | |||||
| Adoption of ASC 326 | |||||
Loading...